Postdoctoral Fellow - Neuroscape
UCSF – Mission BaySandler Neuroscience CenterMC 0444, 675 Nelson Rising LaneSan Francisco, CA 94158
Gabby Agin-Liebes is a licensed clinical psychologist. She has over 11 years of experience working as a therapist and investigator on FDA-approved clinical trials with psilocybin at New York University, Yale and UC San Francisco (UCSF). Her research applies quantitative and qualitative methodologies to study the role of emotion regulation and metacognitive processes (e.g., mindfulness/self-compassion and reappraisal) targeted by psychedelic-assisted therapies for the treatment of addiction, existential distress, and PTSD. Her 2020 study, which found that psilocybin-assisted therapy was associated with improvements 4.5 years after treatment, garnered media attention in several global news outlets including Time, Newsweek, and CNN.
She is passionate about the equitable and ethical use of psychedelic medicines and in disseminating education about their benefits and risks. She is a founding member of the Equity in Psychedelic Therapy Initiative and holds a certificate in Intersectionality & Equity in Therapeutic Practices from the California Institute of Integral Studies.
She holds a small private practice in Berkeley CA where she provides somatic-focused talk therapy and ketamine-assisted psychotherapy. Learn more at https://www.gabbyphd.com.